Thus, as FABP5 is upregulated in several cancer types, it is expected to be a promising prognostic or therapeutic biomarker candidate in these cancers; however, the precise molecular mechanisms underlying FABP5 upregulation and its oncogenic effects in cancer cells remain unclear, despite the extensive efforts of many research groups attempting to clarify the mechanisms. Here, FABP5 is linked to cancer.